We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hikma Pharmaceuticals Plc | LSE:HIK | London | Ordinary Share | GB00B0LCW083 | ORD SHS 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
15.00 | 0.85% | 1,789.00 | 1,797.00 | 1,798.00 | 1,801.00 | 1,769.00 | 1,792.00 | 1,087,265 | 16:35:03 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.88B | 192M | 0.8685 | 20.70 | 3.98B |
TIDMHIK TIDM0H7D
RNS Number : 9675V
Hikma Pharmaceuticals Plc
08 November 2017
TR-1: Standard form for notification of major holdings
LONDON, 8 November 2017 - Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (DIFX: HIK)
(LEI: 549300BNS685UXH4JI75), the fast-growing multinational pharmaceuticals group, announces as
follows:
NOTIFICATION OF MAJOR HOLDINGS ---------------------------------------------------------------------------------------------------- 1a. Identity of the issuer Hikma Pharmaceuticals Plc or the underlying issuer of existing shares to which voting rights are attached(ii) : ------------------------------------------------- ------------------------------------------------- 1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) ---------------------------------------------------------------------------------------------------- Non-UK issuer ------------------------------------------------------------------------------------- ------------- 2. Reason for the notification (please mark the appropriate box or boxes with an "X") ---------------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights x ------------------------------------------------------------------------------------- ------------- An acquisition or disposal of financial instruments ------------------------------------------------------------------------------------- ------------- An event changing the breakdown of voting rights ------------------------------------------------------------------------------------- ------------- Other (please specify)(iii) : ------------------------------------------------------------------------------------- ------------- 3. Details of person subject to the notification obligation(iv) Name Deutsche Bank AG City and country of registered Frankfurt, Germany office (if applicable) 4. Full name of shareholder(s) (if different from 3.)(v) ---------------------------------------------------------------------------------------------------- Name ------------------------------------------------- ------------------------------------------------- City and country of registered office (if applicable) ------------------------------------------------- ------------------------------------------------- 5. Date on which the threshold 06.11.2017 was crossed or reached(vi) : ------------------------------------------------- ------------------------------------------------- 6. Date on which issuer notified 08.11.2017 (DD/MM/YYYY): ------------------------------------------------- ------------------------------------------------- 7. Total positions of person(s) subject to the notification obligation ---------------------------------------------------------------------------------------------------- % of voting % of voting Total of Total number rights attached rights through both in % of voting to shares financial (8.A + 8.B) rights of (total of instruments issuer(vii) 8. A) (total of 8.B 1 + 8.B 2) ---------------------- ------------------------- ---------------- ---------------- ------------- Resulting situation on the date on which threshold was crossed or reached 3.63% 3.56% 7.19% 240,655,680 ---------------------- ------------------------- ---------------- ---------------- ------------- Position of previous notification (if applicable) 3.23% 3.25% 6.48% ---------------------- ------------------------- ---------------- ---------------- ------------- 8. Notified details of the resulting situation on the date on which the threshold was crossed or reached(viii) -------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares -------------------------------------------------------------------------------------------------------------- Class/type Number of voting rights(ix) % of voting rights of shares ISIN code (if possible) ---------------------- Direct Indirect Direct Indirect (Art 9 of (Art 10 of (Art 9 of (Art 10 of Directive Directive Directive Directive 2004/109/EC) 2004/109/EC) 2004/109/EC) 2004/109/EC) (DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1) --------------------- --------------------- -------------- ------------------------------ --------------- GB00B0LCW083 8,705,270 33,428 3.62% 0.01% ---------------------- --------------------- -------------- ------------------------------ --------------- SUBTOTAL 8. A 8,738,698 3.63% ---------------------- ------------------------------------- ----------------------------------------------- B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a)) -------------------------------------------------------------------------------------------------------------- Type of financial Expiration Exercise/ Number of voting % of voting instrument date(x) Conversion rights that rights Period(xi) may be acquired if the instrument is exercised/converted. ---------------------- --------------------- -------------- ------------------------------ --------------- Right To Recall 310,326 0.13% ---------------------- --------------------- -------------- ------------------------------ --------------- SUBTOTAL 8. B 1 310,326 0.13% -------------- ------------------------------ --------------- B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) -------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Physical Number % of voting financial date(x) Conversion or cash of voting rights instrument Period settlement(xii) rights (xi) --------------------- ---------------------- -------------- ----------------- ----------- --------------- Swaps 20-Aug-24 Cash 8,264,526 3.43% --------------------- ---------------------- -------------- ----------------- ----------- --------------- SUBTOTAL 8.B.2 8,264,526 3.43% ----------------- ----------- --------------- 9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X") Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer(xiii) Full chain of controlled undertakings through which x the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity(xiv) (please add additional rows as necessary) ----------------------------------------------------------------- --------------------- Name(xv) % of voting % of voting Total of both rights if it rights through if it equals equals or is financial instruments or is higher higher than if it equals than the notifiable the notifiable or is higher threshold threshold than the notifiable threshold -------------------- ---------------- ----------------------- ----------------------- Deutsche Bank Aktiengesellschaft -------------------- ---------------- ----------------------- ----------------------- DB U.S. Financial Markets Holding
Corporation -------------------- ---------------- ----------------------- ----------------------- DB U.S. Financial Markets Holding Corporation -------------------- ---------------- ----------------------- ----------------------- Deutsche Bank Securities Inc -------------------- ---------------- ----------------------- ----------------------- 10. In case of proxy voting, please identify: ---------------------------------------------------------------------------------------- Name of the proxy holder -------------------------------------- ------------------------------------------------ The number and % of voting rights held -------------------------------------- ------------------------------------------------ The date until which the voting rights will be held -------------------------------------- ------------------------------------------------ 11. Additional information(xvi) ---------------------------------------------------------------------------------------- Place of completion Birmingham -------------------- ----------- Date of completion 08.11.2017 -------------------- -----------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUWSNRBAAARAA
(END) Dow Jones Newswires
November 08, 2017 11:45 ET (16:45 GMT)
1 Year Hikma Pharmaceuticals Chart |
1 Month Hikma Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions